Premium
The mammalian target of rapamycin inhibitor everolimus suppresses proliferation, metabolic activity and collagen synthesis of human fibroblasts in vitro and exerts antifibrogenic effects in vivo
Author(s) -
Böhm M.,
Stegemann A.,
Metze D.,
ScharffetterKochanek K.,
Sindrilaru A.
Publication year - 2017
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.15421
Subject(s) - everolimus , in vivo , in vitro , sirolimus , pharmacology , cancer research , chemistry , medicine , biochemistry , biology , microbiology and biotechnology